Cannabielsoin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Cannabielsoin
Cannabielsoin.png
CBE 3D BS.png
Names
IUPAC name
(5aS,6S,9R,9aR)-6-methyl-3-pentyl-9-prop-1-en-2-yl-7,8,9,9a-tetrahydro-5aH-dibenzofuran-1,6-diol
Other names
  • Cannabielsoin A
  • CBE
  • Cannabielsoin I[1]
Identifiers
3D model (JSmol)
Abbreviations CBE
ChemSpider
KEGG
UNII
  • InChI=1S/C21H30O3/c1-5-6-7-8-14-11-16(22)19-17(12-14)24-20-18(19)15(13(2)3)9-10-21(20,4)23/h11-12,15,18,20,22-23H,2,5-10H2,1,3-4H3/t15-,18+,20-,21-/m0/s1
    Key: RBEAVAMWZAJWOI-MTOHEIAKSA-N
  • CCCCCC1=CC(=C2[C@H]3[C@@H](CC[C@]([C@H]3OC2=C1)(C)O)C(=C)C)O
Properties
C21H30O3
Molar mass 330.468 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Cannabielsoin (CBE) is a metabolite of cannabidiol, one of the major chemical components of cannabis.[2]

History[edit]

Cannabielsoin in scientific journals was first cited in 1973. It was concluded that cannabielsoin was formed from cannabidiol as part of the metabolic process and is non-psychoactive.[3][unreliable source?]

See also[edit]

References[edit]

  1. ^ "Cannabielsoin (CAS 52025-76-0)". www.caymanchem.com.
  2. ^ Yamamoto I, Gohda H, Narimatsu S, Watanabe K, Yoshimura H (November 1991). "Cannabielsoin as a new metabolite of cannabidiol in mammals". Pharmacology, Biochemistry, and Behavior. 40 (3): 541–6. doi:10.1016/0091-3057(91)90360-e. PMID 1806944. S2CID 21038637.
  3. ^ "Cannabielsoin (CBE) Cannabis". Marijuana Doctors.